A
Alnylam Pharmaceuticals, Inc. (ALNY)
NMS – Real Time Price. Currency in USD
222.23
+1.03 (0.47%)
Market open: Aug 12, 2026, 12:50 PM EDT
221.69
+0.49 (0.22%)
Previous after-hours: Aug 11, 2026, 7:56 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
222.23
+1.03 (0.47%)
Market open: Aug 12, 2026, 12:50 PM EDT
221.69
+0.49 (0.22%)
Previous after-hours: Aug 11, 2026, 7:56 PM EDT
This stock has a consensus price target of $430.10 based on the ratings of 32 analysts. The high is $583.00 and the low is $300.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 300 | $ 430.1 | $ 583 |
| Change | 35.62% | 94.44% | 163.56% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2026-08-03 | 87.34% | Raymond James | $420 → $420 | Upgrades | Outperform → Strong Buy |
| 2026-08-03 | 51.66% | Citigroup | $380 → $340 | Maintains | Buy |
| 2026-08-03 | 100.72% | Barclays | $527 → $450 | Maintains | Overweight |
| 2026-07-31 | 67.27% | JP Morgan | $400 → $375 | Maintains | Overweight |
| 2026-07-31 | 56.12% | RBC Capital | $445 → $350 | Maintains | Outperform |